Atlas Trials

Neuromyelitis Optica (NMO) & Cetirizine

Clinical trial NCT02865018 · COMPLETED

Trial details

NCT number
NCT02865018
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuromyelitis Optica
Start date
2014-04-01
Primary completion
2016-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.